Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms
- Written by PR Newswire
Results Highlights for Interim Results ended 30 June 2024
Revenue reached RMB981.8 millionGross profit amounted to RMB339.1 millionNet profit grew by 956.0 YoY to RMB144.2 millionAdjusted non-IFRS net profit reached RMB168.2 million, increased by 15.1% YoY
HONG KONG, Aug. 29, 2024 /PRNewswire/ -- On August 29, 2024, Viva Biotech Holdings Group...














